MXCT
Maxcyte, Inc.
A maker of electroporation instruments and technology that help scientists slip genetic material like mRNA and DNA into living cells — a key step in building cell and gene therapies and vaccines. Its Flow Electroporation platform is used by biopharma companies and researchers to engineer cells for treating disease. Founded in 1999 in Gaithersburg, Maryland, the company's name blends "maximum" and "cyte" (the Greek root for cell), reflecting its goal of getting the most out of every engineered cell.
CUSIP: 57777K106HealthcareUS1 holder
Total Value
$132.2K
Total Shares
83.7K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
